EFALIZUMAB for Pustular psoriasis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 101 adverse event reports in the FDA FAERS database where EFALIZUMAB was used for Pustular psoriasis.
Most Reported Side Effects for EFALIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 56 | 24.4% | 56 | 2 |
| Psoriasis | 55 | 23.9% | 3 | 13 |
| Pruritus | 35 | 15.2% | 8 | 1 |
| Erythema | 28 | 12.2% | 4 | 0 |
| Drug ineffective | 26 | 11.3% | 3 | 6 |
| Pain | 25 | 10.9% | 10 | 1 |
| Decreased appetite | 24 | 10.4% | 0 | 0 |
| Hypersensitivity | 24 | 10.4% | 1 | 1 |
| Vomiting | 24 | 10.4% | 0 | 2 |
| Nausea | 23 | 10.0% | 1 | 0 |
| Condition aggravated | 22 | 9.6% | 0 | 8 |
| Myalgia | 22 | 9.6% | 0 | 0 |
| Fatigue | 20 | 8.7% | 0 | 0 |
| Skin exfoliation | 19 | 8.3% | 5 | 0 |
| Skin plaque | 12 | 5.2% | 6 | 0 |
Other Indications for EFALIZUMAB
Other Drugs Used for Pustular psoriasis
APREMILAST (349)
SECUKINUMAB (317)
ADALIMUMAB (207)
METHOTREXATE (159)
CYCLOSPORINE (157)
ETANERCEPT (146)
INFLIXIMAB (144)
ACITRETIN (129)
USTEKINUMAB (120)
IXEKIZUMAB (81)